Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001087935 | SCV001119528 | likely benign | Immunodeficiency, common variable, 7 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000971854 | SCV001150600 | likely benign | not provided | 2020-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001087935 | SCV004180448 | likely benign | Immunodeficiency, common variable, 7 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000971854 | SCV005261182 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ARUP Laboratories, |
RCV000971854 | SCV005877075 | likely benign | not provided | 2024-07-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004553491 | SCV004719166 | likely benign | CR2-related disorder | 2020-03-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |